Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Gold Fields Limited (GFI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Gold Fields Limited — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Gold Fields Limited trades at $36.7 (market cap $31.26B). The key difference: Gold Fields Limited is far larger — about 6.6× Definium Therapeutics Inc. Common Shares's market cap, and Gold Fields Limited pays a 6.14% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Gold Fields Limited for 49 Days on average.
| DFTX | GFI | |
|---|---|---|
Market Cap | $4.71B | $31.26B |
Volume | 1,966,636 | 3,397,922 |
Sector | Health | Basic Materials |
52-Week High | $48.45 | $61.52 |
52-Week Low | $10.68 | $31.25 |
Typical Hold Time | 0 Days | 49 Days |
Enterprise Value | $3.67B | $31.87B |
Dividend Yield | — | 6.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Gold Fields (GFI) trades at $35.86, down 0.86% with bearish technical signals but strong fundamentals including 40.76% net margin and 58.38% ROE. Recent earnings show mixed results with one beat and three misses against expectations. The company's proposed $27 billion takeover of Northern Star was rejected, creating near-term uncertainty while highlighting growth ambitions. Operating cash flow surged to $3.77 billion in 2025, supporting robust shareholder returns.
GFI presents a value opportunity with low P/E of 7.14 and 44% upside to consensus target of $52.75, though recent acquisition volatility and earnings misses warrant caution. The stock's bearish technical posture contrasts with strong cash generation and analyst support (8 Buy, 10 Hold ratings), creating potential for recovery as standalone operations deliver growth.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Gold Fields Limited
Gold Fields Ltd is a producer of gold and is a holder of gold reserves and resources in South Africa, Ghana, Australia and Peru. In Peru, the company also produces copper. The company is primarily involved in underground and surface gold and surface copper mining and silver and related activities, including exploration, extraction, processing and smelting. It conducts underground and surface mining operations at St. Ives, underground-only operations at Agnew, Granny Smith and South Deep and surface-only open pit mining at Damang, Tarkwa and Cerro Corona. The company's revenues are derived from the sale of gold that it produces.
Read more on GFI →
